Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00017680
What this trial is testing

Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis

Who this might be right for
Amyloidosis
Herbert Irving Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT03342196
What this trial is testing

Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation

Who this might be right for
Leukemia
Case Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT07276386
What this trial is testing

Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute 18
Not applicableStudy completedNCT02504190
What this trial is testing

Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM)

Who this might be right for
Lymphoma
Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 95
Testing effectiveness (Phase 2)Study completedNCT00792142
What this trial is testing

Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell NeoplasmNeurotoxicity
City of Hope Medical Center 45
Early research (Phase 1)Temporarily pausedNCT03494569
What this trial is testing

Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia+5 more
City of Hope Medical Center 36
Not applicableApproved For MarketingNCT04534322
What this trial is testing

Expanded Access Program for Melphalan Flufenamide (Melflufen) in Triple Class Refractory Multiple Myeloma

Who this might be right for
Relapsed and/or Refractory Multiple Myeloma
Oncopeptides AB
Testing effectiveness (Phase 2)Ended earlyNCT00635024
What this trial is testing

Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 1
Early research (Phase 1)UnknownNCT04937634
What this trial is testing

Pharmacokinetic Study of Melphalan in Pediatric Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell Transplantation
Seoul National University Hospital 20
Early research (Phase 1)Study completedNCT00001507
What this trial is testing

Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer

Who this might be right for
Breast NeoplasmNeoplasm Metastasis
National Cancer Institute (NCI) 107
Testing effectiveness (Phase 2)Looking for participantsNCT05870995
What this trial is testing

Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia

Who this might be right for
Refractory Leukemia
Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT00582933
What this trial is testing

Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor

Who this might be right for
LeukemiaMyelodysplastic SyndromeNon-Hodgkin's Lymphoma+1 more
Memorial Sloan Kettering Cancer Center 96
Testing effectiveness (Phase 2)Ended earlyNCT02573935
What this trial is testing

Clarithromycin in Multiple Myeloma Induction Therapy

Who this might be right for
Multiple Myeloma
Henrik Gregersen 58
Testing effectiveness (Phase 2)Study completedNCT00807599
What this trial is testing

Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 67
Testing effectiveness (Phase 2)Study completedNCT00182793
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT00288626
What this trial is testing

High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 25
Large-scale testing (Phase 3)Study completedNCT00934154
What this trial is testing

Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Cigdem Sahinbas YILMAZ 122
Early research (Phase 1)WithdrawnNCT05228249
What this trial is testing

Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements+7 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00205764
What this trial is testing

Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy

Who this might be right for
Multiple Myeloma
Austrian Forum Against Cancer 212
Large-scale testing (Phase 3)Study completedNCT02288741
What this trial is testing

Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy

Who this might be right for
Multiple Myeloma
WiSP Wissenschaftlicher Service Pharma GmbH 549
Next Page